Localization of CYP4B1 in the rat nasal cavity and analysis of CYPs as secreted proteins

Journal of Biochemical and Molecular Toxicology

Volumn 20, Issue 3, 2006, Pages 139-141

  Genter, Mary Beth ^a   Yost, Garold S ^b   Rettie, Allan E ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

CYP4B1; Cytochrome P450; Hepatitis; Nasal Cavity; Secretion

Indexed keywords

AMINO ACID; CYTOCHROME P450; CYTOCHROME P450 4B1;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; COMPUTER ANALYSIS; DATA ANALYSIS SOFTWARE; ENZYME RELEASE; IMMUNOREACTIVITY; LIVER DISEASE; NONHUMAN; NOSE CAVITY; NUCLEOTIDE SEQUENCE; OLFACTORY EPITHELIUM; PREDICTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SEQUENCE ANALYSIS;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; HUMANS; NASAL CAVITY; NASAL MUCOSA; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33745806594     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20123     Document Type: Article

References (15)

1. Smith PB, Tiano HF, Nesnow S, Boyd MR, Philpot RM, Langenbach R. 4-Ipomeanol and 2-aminoanthracene cytotoxicity in C3H/10T1/2 cells expressing rabbit cytochrome P450 4B1. Biochem Pharmacol 1995;50:1567-1575.
2. Henne KR, Fisher MB, Iyer KR, Lang DH, Trager WF, Rettie AE. Active site characteristics of CYP4B1 probed with aromatic ligands. Biochemistry 2001;40:8597-8605.
3. Lanza DL, Yost GS. Selective dehydrogenation/ oxygenation of 3-methylindole by cytochrome P450 enzymes. Drug Metab Dispos 2001;29:950-953.
4. Poch MT, Cutler NS, Yost GS, Hines RN. Molecular mechanisms regulating human CYP4B1 lung-selective expression. Drug Metab Dispos 2005;33:1174-1184.
5. Zhang X, Zhang QY, Liu D, Su T, Weng Y, Ling G, Chen Y, Gu J, Schilling B, Ding X. Expression of cytochrome p450 and other biotransformation genes in fetal and adult human nasal mucosa. Drug Metab Dispos 2005;33:1423-1428.
6. Genter MB, Burman DM, Vijayakumar S, Ebert CL, Aronow BJ. Genomic analysis of alachlor-induced oncogenesis in rat olfactory mucosa. Physiol Genomics 2002;12:35-45.
7. Baldwin RM, Jewell WT, Fanucchi MV, Plopper CG, Buckpitt AR. Comparison of pulmonary/nasal CYP2F expression levels in rodents and rhesus macaque. J Pharmacol Exp Ther 2004;309:127-136.
8. Rettie AE, Sheffels PR, Korzekwa KR, Gonzalez FJ, Philpot RM, Baillie TA. CYP4 isozyme specificity and the relationship between omega-hydroxylation and terminal desaturation of valproic acid. Biochemistry 1995;34:7889-7895.
9. Ritter JK, Owens IS, Negishi M, Nagata K, Sheen YY, Gillette JR, Sasame HA. Mouse pulmonary cytochrome P-450 naphthalene hydroxylase: cDNA cloning, sequence, and expression in Saccharomyces cerevisiae. Biochemistry 1991;30:11430-11437.
10. Nielsen H, Engelbrecht J, Brunak S, von Heijne G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng 1997;10:1-6.
11. Bendtsen JD, Nielsen H, von Heijne G, Brunak S. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004;340:783-795.
12. Marceau G, Lapierre P, Beland K, Soudeyns H, Alvarez F. LKM1 autoantibodies in chronic hepatitis C infection: A case of molecular mimicry? Hepatology 2005;42:675-682.
13. Kato T, Miyakawa H, Ishibashi M. Frequency and significance of anti-glutathione S-transferase autoantibody (anti-GST A1-1) in autoimmune hepatitis. J Autoimmun 2004;22:211-216.
14. Mizutani T, Shinoda M, Tanaka Y, Kuno T, Hattori A, Usui T, Kuno N, Osaka T. Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2. Drug Metab Rev 2005;37:235-252.
15. Dalekos GN, Obermayer-Straub P, Bartels M, Maeda T, Kayser A, Braun S, Loges S, Schmidt E, Gershwin ME, Manns MP. Cytochrome P450 2A6: A new hepatic autoantigen in patients with chronic hepatitis C virus infection. J Hepatol 2003;39:800-806.